Please login to the form below

Not currently logged in
Email:
Password:

Cinquil

This page shows the latest Cinquil news and features for those working in and with pharma, biotech and healthcare.

CHMP backs GSK's asthma antibody and Novartis' heart failure drug

CHMP backs GSK's asthma antibody and Novartis' heart failure drug

GSK is racing to market alongside other IL-5 inhibitor developers including Teva, which has filed its Cinquil (reslizumab) candidate, and AstraZeneca which is due to submit benralizumab for approval next

Latest news

  • Teva set for FDA verdict on reslizumab early next year Teva set for FDA verdict on reslizumab early next year

    Teva set for FDA verdict on reslizumab early next year. Ruling for severe asthma therapy Cinquil expected by March 2016. ... The clock has started ticking on Teva's US marketing application for severe asthma therapy Cinquil, with an FDA ruling now

  • GSK’s new asthma biologic gains FDA panel backing GSK’s new asthma biologic gains FDA panel backing

    Mepolizumab is also vying with other new drug candidates in late-stage trials for severe asthma, notably AstraZeneca's benralizumab and Teva's Cinquil (reslizumab), both IL-5 inhibitors, as well

  • GSK set to file severe asthma candidate by year-end GSK set to file severe asthma candidate by year-end

    Mepolizumab is also vying with other new drug candidates in late-stage trials for severe asthma, notably AstraZeneca's benralizumab and Teva's Cinquil (reslizumab), both IL-5 inhibitors, as well

  • AZ takes severe asthma antibody into phase III AZ takes severe asthma antibody into phase III

    Benralizumab - which was originally licensed from Japanese company BioWa - is in the same drug class as Teva's Cinquil (reslizumab) and GlaxoSmithKline's mepolizumab, which are both already in phase III

  • Advancing acquisitions

    It acquired Ception via an option enabling Cephalon to judge the performance of Cinquil in phase II studies before taking up the option. ... 272. Ipsen/Inspiration Biopharmaceuticals . haemophilia franchise. Acquisition, various . 259. Ception/Cephalon.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The Holy Grail of HCP Access
This is the data you need to gain access....
No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....

Infographics